The COVID-19 pandemic has made people more conscious of their personal health than ever before and has brought stark reality to the devastating impact that infections can have. Coined as the ‘hidden pandemic’, concerns are rising that antibiotic resistant infections are already presenting the next global health crisis.
The global impact of COVID-19 has shone a light on the need to reconsider infection management as a whole. That’s why, earlier this year, the Infection Management Coalition (IMC) launched a new White Paper calling for transformational change in the way infection is detected, monitored, prevented, and managed across all facets of the NHS, healthcare systems and broader society.
Developed by a diverse coalition of partners spanning pharmaceuticals, patient organisations, MedTech and diagnostics, the paper calls for a whole system approach to infection management which addresses outbreak and pandemic preparedness, infection prevention, rapid treatment of time-critical viral and bacterial infection, and the delivery of effective antimicrobial stewardship. Building on the findings discussed in the Lancet’s global report on the burden of AMR1, the White Paper outlines the ways in which we can, and must, come together to deliver this holistic change.
Through its summary of recommendations, the report identifies the owners, timelines and required actions within 4 key areas:
Diagnostics and treatment
Awareness and education
As a next step, the IMC is calling for the development of cohesive policy to support its roadmap of action. This includes working collectively to publish holistic infection management plans that support both immediate and long-term changes for the better.
Infection Management Coalition Paper
Published February 2022.
- Antimicrobial Resistance Collaborators (2022). Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. The Lancet, 399:10325, 629-655. Accessed February 2022.
PP-UNP-GBR-0075 / February 2022